Clinical Trials Logo

Uterine Cervicitis clinical trials

View clinical trials related to Uterine Cervicitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT05675293 Not yet recruiting - CERVICITIS Clinical Trials

Cervicitis by Iontophoresis

Start date: January 15, 2023
Phase: Early Phase 1
Study type: Interventional

The purpose of the study is to: Investigate effect of iontophoresis on managing uterine cervicitis.

NCT ID: NCT05564299 Recruiting - Clinical trials for Sexually Transmitted Infections

Rapid Diagnostic Assay for Gonorrhea and Chlamydia

Start date: March 22, 2023
Phase: N/A
Study type: Interventional

This study is a pilot randomized controlled trial evaluating the use of either a) rapid 30-minute desktop assay or b) point-of-care gram stain (current standard of care) to guide the clinical management of patients with symptomatic urethritis or cervicitis evaluated in the Massachusetts General Hospital Sexual Health Clinic. Patients presenting with symptoms of urethritis or cervicitis and meeting inclusion criteria will be randomized to have diagnostic specimens tested during the clinical encounter using either the 30-minute desktop assay or point-of-care gram stain. Patients randomized to the intervention arm of the study will also have a gram stain created, which will be held for interpretation by the clinician following the clinical encounter. Patients will not be followed longitudinally. Recruitment will conclude when 100 participants enroll in the study.

NCT ID: NCT04809727 Completed - Cancer of Cervix Clinical Trials

Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

HSTH
Start date: December 1, 2017
Phase: N/A
Study type: Interventional

Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical biopsy was done and histopathological examinations were done to evaluate the pathology in these patients.

NCT ID: NCT01375439 Completed - Pregnancy Clinical Trials

Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous Pregnancy

Start date: August 2011
Phase: N/A
Study type: Interventional

Introduction: Preterm labor (PTL) is an important obstetric intercurrence that affects 5 to 10% of pregnancies. Among the known factors of PTL etiology are PTL occurrence in previous pregnancies, multiple pregnancies, polyhydramnios, vaginal bleeding during pregnancy, premature membrane rupture (PMR) and bacterial vaginosis. Despite the advancement achieved in Neonatology, morbidity and mortality resulting from high rates of preterm births have remained constant in the last few decades. Objective: This study aims at evaluating maternal and perinatal outcomes of pregnant women with a history of preterm labor in previous pregnancies and submitted to active search for vaginal infection. Material and Method: It is a prospective-cohort epidemiological study to be conducted in Botucatu/SP. Two study groups (G1 and G2) will be formed, and each of them will comprise 140 pregnant women with a history of preterm childbirth. G1 will be related to the active search and etiological diagnosis of lower genital tract infections, and G2 will be related to non-search for such infections, for which the routine care protocol of primary health units in the city of Botucatu will be maintained. Care propedeutics for the pregnant women (G1) will include the performance of direct examination of vaginal content stained by the Gram method, culture in Diamonds medium, polymerase chain reaction (PCR) of endocervical secretion collected in the primary health care services in the city at two moments: prior to the 20th gestational week (M1) and at the 36th week (M2). Moment M3 will take place after childbirth for evaluation of the perinatal outcome.

NCT ID: NCT01072136 Terminated - Cervicitis Clinical Trials

Empiric Therapy of Mucopurulent Cervicitis (MPC)

Start date: March 2010
Phase: Phase 3
Study type: Interventional

Mucopurulent cervicitis (MPC) is a syndrome with associated symptoms including mucopurulent discharge (mucus and pus) from the cervix and other signs of inflammation such as easily induced cervical bleeding. The purpose of this study is to evaluate the effectiveness of no treatment versus empiric treatment with a single dose of cefixime and azithromycin for cure of MPC. Empiric treatment is the initiation of treatment prior to a firm diagnosis. Study participants will include 772 women ages 18 and older in good health with MPC. Women will be randomly assigned to 1 of 2 possible study groups: Group 1 will receive a single dose of cefixime and azithromycin antibiotics and Group 2 will receive placebo (inactive substance). Study procedures will include pelvic examination with a cervical swab sample. Participants will be involved in study related procedures for approximately 2 months, which includes 3 study visits.